Global Oncology Intelligence
Get answers for your key business and research needs
Brand Team
How is my brand being used in the real-world setting?
Business Intelligence Team
How is the competitive landscape evolving?
Market Access Team
How does the patient journey and standard of care differ across countries?
HEOR Team
How is the testing rate for key biomarkers evolving over time?
Pipeline and BD Team
Which patient populations are underserved with effective therapies?
Clinical Operations and Study Teams
Does my clinical study protocol reflect real-world populations and clinical practice?
How do healthcare stakeholders utilize Global Oncology Intelligence data
How is the competitive landscape evolving?
How is my brand being used in the real-world setting?
How does the patient journey and standard of care differ across countries?
How is the testing rate for key biomarkers evolving over time?
Which patient populations are underserved with effective therapies?
Does my clinical study protocol reflect real-world populations and clinical practice?
Quantify the cost of drug therapies by better understanding of the real-world standard of care. Size the market. Benchmark against competitor performance.
Examine drug utilization and treatment patterns to evaluate the real-world standard of care. Adoption.
Evaluate current standard of care. How does patient journey and standard of care differ across countries?
Benchmark adherence to clinical guidelines. Does my study protocol reflect real world populations and clinical practice? Compare biomarker testing rates.
Understand patient profiles and
sub-populations. Which patient pops
are underserved? Treatment pathways.
Inform on study protocols and feasibility.